DILTIAZEM PROVIDES ANTIISCHEMIC AND ANTIARRHYTHMIC PROTECTION IN PATIENTS UNDERGOING CORONARY-BYPASS GRAFTING

被引:31
作者
HANNES, W [1 ]
FASOL, R [1 ]
ZAJONC, H [1 ]
SCHINDLER, M [1 ]
SCHUMACHER, B [1 ]
SCHLOSSER, V [1 ]
HOLUBARSCH, CH [1 ]
SEITELBERGER, R [1 ]
机构
[1] UNIV FREIBURG,DEPT CARDIOVASC SURG,W-7800 FREIBURG,GERMANY
关键词
DILTIAZEM; CORONARY BYPASS SURGERY; MYOCARDIAL ENZYMES; HOLTER MONITORING;
D O I
10.1016/1010-7940(93)90211-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 91 patients undergoing elective coronary bypass grafting, the anti-ischemic and anti-arrhythmic efficacy of a 24-hour infusion of either the calcium antagonist diltiazem (0.1 mg/kg per h, n = 44) or nitroglycerin (1 mug/kg per min, n = 47) were compared. Myocardial ischemia was diagnosed by Holter monitoring and the repeated assessment of 12-lead ECG and serum enzyme levels and defined as a transient ischemic event, transient coronary spasm or myocardial infarction. The two groups did not differ with respect to preoperative and operative data. Postoperatively, the average heart rate and pulse pressure rate were significantly lower in the diltiazem group. The incidence of postoperative atrial fibrillation (4.5 vs 19.1 %, P < 0.01), transient coronary spasm (2.3 vs 11.4 %, P < 0.05) and myocardial infarction (4.5 vs 8.5 %, not significant) and the frequency of ventricular premature couplets/h (12.1 +/- 4.5 vs 18.1 +/- 5.1, P < 0.05) and ventricular runs/h (2.5 +/- 0.8 vs 6.5 +/- 2.8, P < 0.05) were lower in the diltiazem as compared to the nitroglycerin group. In addition, diltiazem-treated patients had significantly lower postoperative peak values of creatine kinase-MB (19.3 +/- 11.6 vs 29.3 +/- 20.6, P < 0.05). In conclusion, perioperative infusion of diltiazem is effective in reducing the incidence and extent of arrhythmias and myocardial ischemia in patients undergoing elective coronary bypass grafting as compared to patients receiving nitroglycerin.
引用
收藏
页码:239 / 245
页数:7
相关论文
共 34 条
[11]  
Henling C.E., Slogoff S., Kodali V., Arlund C., Heart block after coronary artery bypass effect of chronic administration of calcium entry blockers and P-blockers, Anesth Analg, 63, pp. 515-520, (1984)
[12]  
Larach D.R., Hensley F.A., Pae W.A., Derr J.A., Campbell D.B., Diltiazem withdrawal before coronary artery bypass surgery, J Cardiothorac Anesthesia, 3, pp. 688-699, (1989)
[13]  
Li W., Hanelin L.G., Riggins R.C., Agnew R.C., Annest L.S., Erson R.P., Perioperative ischemic injury after coronary bypass graft surgery, Am J Surg, 150, pp. 122-126, (1985)
[14]  
Lichtenstein S.V., Ashe K.A., El Dalati H., Cusimano R.J., Panos A., Slutsky A.S., Warm heart surgery, J Thorac Cardiovasc Surg, 101, pp. 269-274, (1991)
[15]  
Mangano D.T., The Study of Perioperative Ischemia, Research Group, 5, pp. 288-293, (1990)
[16]  
Matsuzaki M., Gallagher K.P., Patritti J., Tajimi T., Kemper W.S., White F.C., Ross J., Effects of calcium-entry blocker (Diltiazem) on regional myocardial flow and function during exercise in conscious dogs, Circulation, 69, pp. 801-814, (1984)
[17]  
Matsuzaki M., Patritti J., Tajimi T., Miller M., Kemper W.S., Effects of b blockade on regional myocardial flow and function during exercise, Am J Physiol, 247, pp. 52-60, (1984)
[18]  
Matsuzaki M., Guth B., Tajimi T., Kemper W.S., Ross J., Effects of the combination of diltiazem and atenolol on the exercise induced regional myocardial ischemia in conscious dogs, Circulation, 72, pp. 233-243, (1985)
[19]  
McGregor G.A., Muir A.L., Smith A.L., Miller H.C., Hannan W.J., Cameron E., Wheatley D.J., Myocardial infarction related to coronary artery bypass graft surgery, Br Heart J, 51, pp. 399-406, (1984)
[20]  
Melendez F.J., Gharagozloo F., Sun S.C., Benfeli K., Austin R.E., Shemin R., Cohn L.H., Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necrosis after acute coronary artery occlusion and surgical reperfusion, J Thorac Cardiovasc Surg, 95, pp. 613-617, (1988)